The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians to the circulation of counterfeit diabetes medication in parts of the country. The agency warned that the fake products pose serious health risks to patients who rely on the medication to manage their blood sugar levels.
According to NAFDAC, the counterfeit medicine may not contain the correct active ingredients, making it ineffective and potentially dangerous for people living with diabetes. The agency urged patients, healthcare providers, pharmacists, and distributors to remain vigilant and ensure they obtain medicines only from licensed and reputable sources.
NAFDAC advised members of the public to carefully inspect medicine packaging for signs of tampering, incorrect labeling, spelling errors, or unusual batch numbers before use. It also encouraged healthcare professionals to report any suspected counterfeit products to the agency for prompt investigation and regulatory action.
The agency reaffirmed its commitment to safeguarding public health through intensified surveillance and enforcement activities aimed at removing fake medicines from circulation. NAFDAC urged Nigerians to report suspicious medicines through its official reporting channels and stressed that using genuine, approved medications is essential for effective diabetes management and patient safety.
